Dr. Janice M. Mehnert
Claim this profileLaura and Isaac Perlmutter Cancer Center at NYU Langone
Studies Cancer
Studies Tumors
16 reported clinical trials
19 drugs studied
About Janice M. Mehnert
Education:
- Holds an MD (Doctor of Medicine).
Experience:
- Faculty member in the Department of Medicine at NYU Langone Health.
- Serves as the Associate Director of Clinical Research at the Perlmutter Cancer Center.
- Recognized internationally for expertise in early phase clinical trials, especially in skin cancer and advanced cancers.
- Plays a key role in the leadership team at Perlmutter Cancer Center.
- Specializes in skin cancer and phase 1 clinical trials for advanced cancers, with efforts to expand clinical trials across multiple locations.
Area of expertise
1Cancer
Stage IV
Stage III
Stage I
2Tumors
Stage IV
KRAS positive
BRAF positive
Affiliated Hospitals
Clinical Trials Janice M. Mehnert is currently running
GV20-0251
for Cancer
This is a Phase 1 study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory to approved therapies or other standard of care.
Recruiting1 award Phase 1
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting1 award Phase 29 criteria
More about Janice M. Mehnert
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Janice M. Mehnert has experience with
- Nivolumab
- Pembrolizumab
- RP1
- Trametinib
- Ipilimumab
- Cemiplimab
Breakdown of trials Janice M. Mehnert has run
Cancer
Melanoma
Skin Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Janice M. Mehnert specialize in?
Janice M. Mehnert focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Janice M. Mehnert currently recruiting for clinical trials?
Yes, Janice M. Mehnert is currently recruiting for 7 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Janice M. Mehnert has studied deeply?
Yes, Janice M. Mehnert has studied treatments such as Nivolumab, Pembrolizumab, RP1.
What is the best way to schedule an appointment with Janice M. Mehnert?
Apply for one of the trials that Janice M. Mehnert is conducting.
What is the office address of Janice M. Mehnert?
The office of Janice M. Mehnert is located at: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York 10016 United States. This is the address for their practice at the Laura and Isaac Perlmutter Cancer Center at NYU Langone.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.